IQVIA Accelerates Revenue Growth As Biopharma Shifts Toward Outsourcing

Yahoo Finance reports that IQVIA Holdings has tripled its organic revenue growth rate to 6% year-over-year. The healthcare data giant is benefiting from a surge in demand from emerging biopharma firms, which now account for 70% of global clinical trial starts and represent the co

Yahoo Finance reports that IQVIA Holdings has tripled its organic revenue growth rate to 6% year-over-year. The healthcare data giant is benefiting from a surge in demand from emerging biopharma firms, which now account for 70% of global clinical trial starts and represent the co